Peptide Therapeutics CMC: Impurities Management and Control Strategy
Online Event
Date
3–4 June 2026
Subject areas
Industry , Chemical Biology and Medicinal , Organic , Human Health
Location
Peptide therapeutics continue to expand across modalities and indications, yet theirChemistry, Manufacturing and Controls (CMC)present distinctive challenges: complex synthesis routes, diverse impurity profiles (process-, product-, and degradation-related), and evolving regulatory expectations. This course, delivered by Scientific Update, provides a practical, end鈥憈o鈥慹nd framework for developing and executing robustimpurity managementandcontrol strategiesfor peptide drug substances and drug products. Through a combination of technical lectures, case studies, and interactive exercises, participants will learn how to design phase鈥慳ppropriate CMC strategies that accelerate development, reduce risk, and meet global regulatory requirements.